Predicted Disorder Regions | 48-67, 194-210, 269-287, 332-341, 469-527, 541-566, 581-597, 614-625, 714-719, 751-803 |
---|
Bibliography | 1.Hnilicová J, Hozeifi S, Stejskalová E, Dušková E, Poser I, Humpolíčková J, Hof M, Staněk D. The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing. Mol Biol Cell. 2013 Nov;24(22):3557-68. doi: 10.1091/mbc.E13-06-0303. Epub 2013 Sep 18. PMID: 24048450; PMCID: PMC3826993. 2.Zang K, Wang J, Dong M, Sun R, Wang Y, Huang Y, Liu X, Li Y, Wang F, Yu M. Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytes. PLoS One. 2013 Oct 23;8(10):e78536. doi: 10.1371/journal.pone.0078536. PMID: 24194944; PMCID: PMC3806839. 3.Nakamura Y, Umehara T, Nakano K, Jang MK, Shirouzu M, Morita S, Uda-Tochio H, Hamana H, Terada T, Adachi N, Matsumoto T, Tanaka A, Horikoshi M, Ozato K, Padmanabhan B, Yokoyama S. Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4. J Biol Chem. 2007 Feb 9;282(6):4193-201. doi: 10.1074/jbc.M605971200. Epub 2006 Dec 5. PMID: 17148447. |